Effects of indomethacin administration on bone turnover and bone mass in adjuvant-induced arthritis in rats

Calcified Tissue International

Volumn 59, Issue 5, 1996, Pages 385-391

  Aota, S ^a   Nakamura, T ^b   Suzuki, K ^b   Tanaka, Y ^b   Okazaki, Y ^b   Segawa, Y ^c   Miura, M ^d   Kikuchi, S ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c Department of Pharmacology   (Japan)

^d LSI MEDIENCE CORPORATION   (Japan)

Author keywords

Bone formation rate; Histomorphometry; Indomethacin; Osteocalcin; Osteoclast

Indexed keywords

ALKALINE PHOSPHATASE; INDOMETACIN; OSTEOCALCIN; PROSTAGLANDIN;

ADJUVANT DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MASS; BONE MINERALIZATION; BONE TURNOVER; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; INFLAMMATION; LUMBAR VERTEBRA; NONHUMAN; ORAL DRUG ADMINISTRATION; OSSIFICATION; OSTEOCLAST; OSTEOPOROSIS; PRIORITY JOURNAL; RAT;

EID: 0029861141     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002239900144     Document Type: Article

References (41)

1. Sambrook PN, Eisman JA, Champion GD, Yeates MG, Pocock NA, Eberl S (1987) Determinants of axial bone loss in rheumatoid arthritis. Arthritis Rheum 30:721-728
2. Will R, Palmer R, Bhalla AK, Ring F (1989) Osteoporosis in early ankylosing spondylitis: a primary pathological event. Lancet ii: 1483-1487
3. Spector TD, Hall GM, McCloskey EV, Kanis JA (1993) Risk of vertebral fracture in women with rheumatoid arthritis. Br Med J 306:558
4. Michael BA, Bloch DA, Wolfe F, Freis JF (1993) Fractures in rheumatoid arthritis: an evaluation of associated risk factors. J Rheum 20:1666-1669
5. Ralston SR, Urquhart GDK, Brezeski M, Sturrock R (1990) Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis. Br Med J 300:563-565
6. Mellish PWE, O'Sullivan MM, Garrahan NJ, Compston JE (1987) Iliac crest trabecular bone mass and structure in patients with non-steroid treated rheumatoid arthritis. Ann Rheum Dis 46:830-836
7. Compston JE, Crawley EO, Evans C, O'Sullivan MM (1988) Spinal trabecular bone mineral content in patients with non-steroid treated rheumatoid arthritis. Ann Rheum Dis 47:660-664
8. Weichman BM, Chau TT, Rona G (1987) Histopathologic evaluation of the effects of etadolac in established adjuvant arthritis in rats: evidence for reversal of joint damage. Arthritis Rheum 30:466-470
9. Pearson CM, Wood FD (1963) Studies of other lesions induced in rats by the injection of mycobacterial adjuvant. III. Pathologic details of the arthritis and spondylitis. Am J Pathol 42:73-95
10. Bonnet J, Zerath E, Picaud N, Lesur C, Mattio A, Tordjman C, Hott M, Marie PJ (1993) Bone morphometric changes in adjuvant-induced polyarthritic osteopenia in rats: evidence for an early bone formation defect. J Bone Miner Res 8:659-668
11. Segawa Y, Nakamura T, Aota S, Tanaka Y, Yoshida K, Tsuzuike N, Matsuda K (1995) Changes in urinary deoxypyridinoline level and vertebral bone mass in the development of adjuvant-induced arthritis in rats. Bone 17:57-62
12. Langman CB, Ford KK, Pachman LM, Glorieux F (1990) Vitamin D metabolism in rats with adjuvant-induced arthritis. J Bone Miner Res 5:905-913
13. Connerty HV, Briggs AR (1966) Determination of serum calcium by means of orthocresolphthalein complexone. Am J Clin Pathol 45:290-296
14. Drewes PA (1972) Direct colorimetric determination of phosphorus in serum and urine. Clin Chim Acta 39:81-88
15. Scandinavian Society for Clinical Chemistry and Clinical Physiology (1975) Recommended methods for the determination of four enzymes in blood. Scand J Clin Lab Invest 33: 291-306
16. Yamaura M, Nakamura T, Tsurukami H, Hijioka A, Narusawa K, Ohnishi H, Ohta T, Hosoda K (1996) Local bone turnover in the metaphysis of the proximal tibia and the lumbar vertebra during the early periods after ovariectomy in rats. Calcif Tissue Int 58:52-59
17. Andersson GN, Marks SC Jr (1989) Tartrate-resistant acid phosphatase as a cytochemical marker for osteoclasts. J Histochem Cytochem 37:115-121
18. Parfitt AM, Dretzner MK, Glorieux FH, Kanis JA, Malluche HH, Meunier PH, Otto SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols and units. J Bone Miner Res 6:595-610
19. Turner RT (1994) Cancellous bone turnover in growing rats: time-dependent change in association between calcein label and osteoblasts. J Bone Miner Res 9:1419-1424
20. Lane N, Coble T, Kimmel DB (1990) Effect of naproxen on cancellous bone in ovariectomized rats. J Bone Miner Res 5:1029-1035
21. Miller SC, Jee WSS (1975) Ethane-1-hydroxy-1,1-diphosphonate (EHDP) effects on growth and modeling of the rat tibia. Calcif Tissue Res 18:215-231
22. Thompson DD, Rodan GA ( 1988) Indomethacin inhibition of tenotomy-induced bone resorption in rats. J Bone Miner Res 4:409-414
23. Kawaguchi H, Pilbeam CC, Harrison JK, Raiz LG (1995) The role of prostaglandins in the regulation of bone metabolism. Clin Orthop 313:36-46
24. Johnson WJ, Muirhead KA, Meunier PC, Votta BJ, Schmitt TC, Dimartino MJ, Hanna N (1986) Macrophage activation in rat models of inflammation and arthritis. Arthritis Rheum 29: 1122-1130
25. Connoly KM, Stecher VJ, Danis E, Pruden DJ, LaBrie T (1988) Alteration of interleukin-1B activity and the acute phase response in adjuvant arthritic rats treated with disease modifying anti-rheumatic drugs. Agents Actions 25:94-105
26. Leisten JC, Gaarde WA, Scholz W (1990) Interleukin-6 serum levels correlate with footpad swelling in adjuvant-induced arthritic Lewis rats treated with cyclosporin A or indomethacin. Clin Immunol Immunopathol 56:108-115
27. Smith-Oliver T, Noel LS, Stimpson SS, Yarnall DP, Connoly KM (1993) Elevated levels of TNF in the joints of adjuvant arthritic rats. Cytokine 5:298-304
28. Stashenko P, Dewhrist FE, Rooney ML, Dejardins LA, Heeley D (1987) Interleukin-1B is a potent inhibitor of bone formation in vitro. J Bone Miner Res 2:559-565
29. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR (1986) Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature 319:516-518
30. Nguyen L, Dewhrist FE, Hauschka PV, Stashenko P (1991) Interleukin-1B stimulates bone resorption and inhibits bone formation in vivo. Lymphokine Cytokine Res 10:15-21
31. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC (1992) Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257:88-91
32. Kimmel DB, Coble T, Lane N (1992) Long-term effect of naproxen on cancellous bone in ovariectomized rats. Bone 13:167-172
33. 2, plasminogen activator, osteocalcin and alkaline phosphatase by osteoblast-like cells derived from human bone. Biochem Biophys Res Comm 166:208-216
34. Tashjian AH, Voelkel EF, Lazzaro M, Goad D, Bosma T, Levine L (1987) Tumor necrosis factor-a (Cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism. Endocrinology 120:2029-2036
35. Bikle DD, Harris J, Halloran BP, Morey-Holton ER (1994) Skeletal unloading induces resistance to insulin-like growth factor 1. J Bone Miner Res 9:1789-1796
36. Franck H, Keck E (1993) Serum osteocalcin and vitamin D metabolites in patients with ankylosing spondylitis. Ann Rheum Dis 52:343-346
37. Sambrook PN, Ansell BM, Foster S (1985) Bone turnover in early rheumatoid arthritis. 1. Biochemical and kinetic indices. Ann Rheum Dis 44:575-579
38. Kroger H, Risteli J, Risteli L, Penttila, Alhava E (1993) Serum osteocalcin and carboxyterminal propeptide of type 1 procollagen in rheumatoid arthritis. Ann Rheum Dis 52:338-342
39. Gough AKS, Lilley J, Eyre S, Holder RL, Emery P (1994) Generalized bone loss in patients with early rheumatoid arthritis. Lancet 344:23-27
40. Marhoff W, Schatz H, Stracke H, Ulmann J, Schmidt K, Federlin K (1991) Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis. J Rheumatology 18:1158-1162
41. Gevers G, Devos P, DeRoo M, Dequeker J (1986) Increased levels of osteocalcin (serum bone GLA-protein) in rheumatoid arthritis. Br J Rheumatol 25:260-262